To summarize the role of NF-κB signaling in acute myocardial infarction (AMI), emphasizing its context-dependent functions in inflammation and tissue remodeling.
Approach:
Overview of NF-κB Signaling: Describes the activation of NF-κB in response to various stimuli, including cytokines and oxidative stress, and its role in regulating inflammation, cell survival, and apoptosis.
Biphasic Role in AMI: Details how early NF-κB activation contributes to danger-signal recognition and immune-cell recruitment, while sustained activation leads to unresolved inflammation, cardiomyocyte death, and adverse remodeling.
Therapeutic Implications: Discusses the challenges of broad NF-κB inhibition and highlights the need for temporally controlled and cell-selective strategies that preserve reparative inflammation while limiting chronic inflammatory injury.
Key Findings:
NF-κB acts as a biphasic regulator in AMI, supporting early repair through immune response but driving adverse remodeling when persistently activated.
NF-κB integrates DAMP sensing, inflammatory transcription, cardiomyocyte death, fibroblast activation, and ECM remodeling, highlighting its complex role in AMI.
Precision NF-κB modulation should prioritize time-specific, cell-selective, and network-based therapeutic strategies to balance inflammation and repair.
Interpretation:
The role of NF-κB in AMI is multifaceted, with both beneficial and detrimental effects that depend on the timing and context of its activation.
Limitations:
Broad NF-κB inhibition may lead to unwanted side effects due to its essential roles in various cellular processes.
Current understanding of NF-κB signaling in AMI is still evolving, necessitating further research into its complex roles and the challenges of inhibition.
Conclusion:
Targeting NF-κB signaling presents a promising therapeutic strategy, emphasizing the need for temporally controlled and cell-selective approaches to modulate inflammation and fibrosis in AMI.
